Clinical Trial Update: FAPI Imaging Assessment of Chronic Total Occlusion

View source ↗

Summary

An ongoing clinical trial is recruiting to evaluate a FAPI-based imaging tracer for chronic total occlusion, aiming to assess its diagnostic utility in CTO pati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Total Occlusion

Drugs mentioned

• FAPI imaging agent (fibroblast activation protein inhibitor tracer)

Snippet

Sponsor: Lin Zhao | Conditions: Chronic Total Occlusion (CTO) | Status: RECRUITING